Carbonic anhydrase inhibitors can cause nephrolithiasis. We studied 20 patients receiving long-term carbonic anhydrase inhibitor treatment for periodic paralysis and myotonia. Three patients on acetazolamide (15%) developed renal calculi. Extracorporeal lithotripsy successfully removed a renal calculus in one patient and surgery removed a staghorn calculus in another, permitting continued treatment. Renal function remained normal in all patients. Nephrolithiasis is a complication of acetazolamide but does not preclude its use.

Download full-text PDF

Source
http://dx.doi.org/10.1212/wnl.43.6.1105DOI Listing

Publication Analysis

Top Keywords

carbonic anhydrase
8
acetazolamide-induced nephrolithiasis
4
nephrolithiasis implications
4
implications treatment
4
treatment neuromuscular
4
neuromuscular disorders
4
disorders carbonic
4
anhydrase inhibitors
4
inhibitors nephrolithiasis
4
nephrolithiasis studied
4

Similar Publications

Carbonic Anhydrase IX Targeted Polyaspartamide fluorescent Probes for Tumor imaging.

Int J Nanomedicine

January 2025

College of Chemical and Material Engineering, Quzhou University, Quzhou, Zhejiang Province, 324000, People's Republic of China.

Background: Precise intraoperative tumor delineation is essential for successful surgical outcomes. However, conventional methods are often incompetent to provide intraoperative guidance due to lack specificity and sensitivity. Recently fluorescence-guided surgery for tumors to delineate between cancerous and healthy tissues has attracted widespread attention.

View Article and Find Full Text PDF

Background: Some studies have suggested that glaucoma may be associated with neurodegeneration and a higher risk of dementia.

Objective: To evaluate whether exposure to different categories of topical glaucoma medications is associated with differential dementia risks in people with glaucoma.

Methods: We used data from Adult Changes in Thought, a population-based, prospective cohort study that follows cognitively normal older adults from Kaiser Permanente Washington (KPWA) until Alzheimer's disease (AD) and related dementia development.

View Article and Find Full Text PDF

Purpose: This study evaluated the efficacy, safety, and tolerability of a single-dose, preservative-free (PF) Dorzolamide/Timolol combination (Twinzol-SDU).

Methods: A 3-month single-arm, multicenter, prospective cohort study was conducted in Egypt between January 2021 and October 2022 on previously diagnosed and controlled patients with ocular hypertension and/or glaucoma. Efficacy was assessed using the change in intraocular pressure (IOP) after 6 and 12 weeks.

View Article and Find Full Text PDF

Light energy-driven carbonic anhydrase mediate CO sequestration system with variable-temperature adaptability.

Int J Biol Macromol

January 2025

College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an 710021, China; Institute of Biomass & Functional Materials, Shaanxi University of Science & Technology, Xi'an 710021, China. Electronic address:

The escalating atmospheric CO₂ concentration urgently demands ecologically friendly mitigation strategies. Compared to alternative catalysts, carbonic anhydrase (CA) demonstrates exceptionally high catalytic efficiency in CO₂ hydration reactions. Nevertheless, traditional CA immobilization techniques exhibit peak enzymatic activity exclusively at optimal temperatures, consequently constraining their effective application across diverse environmental thermal conditions in industrial settings.

View Article and Find Full Text PDF

Purpose: To review the current evidence on the association between salivary protein profile and dental caries in children during mixed dentition stage.

Methods: This systematic review followed the PRISMA 2020 guidelines. Searches were run in PubMed, Scopus and Embase along with gray literature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!